Solara Active Pharma Sciences has informed that it enclosed the transcript of earnings conference call for the quarter ended June 30, 2026, conducted on Thursday, July 23, 2026, after the meeting of Board of Directors. The above information is also available on the website of Company at: https://solara.co.in/investorrelations/investor-update.
The above information is a part of company’s filings submitted to BSE.